arrow
E

Eduardo Perna

cabral cardiology institute
H指数:21
被引数:3,795

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lp(a) in Argentina: A multicenter study on prevalence and clinical outcomes

Lp(a)在阿根廷:一项关于患病率和临床结局的多中心研究

2025-11-170
PRE
Frailty and Effects of Semaglutide in Obesity-Related HFpEF

虚弱及司美格鲁肽在肥胖相关HFpEF中的效果

2025-09-150
OAAI
IMPACT OF THE NUMBERS OF COMPONENTS OF CARDIO-RENO-METABOLIC SYNDROME PLUS OBESITY ON PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A SUB-ANALYSIS OF THE ARFEY-PRESER REGISTRY
2024-09-010
PRE
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

射血分数保留的肥胖相关心力衰竭患者的Semaglutide与安慰剂: STEP-HFpEF和STEP-HFpEF DM随机试验的汇总分析

LANCET
IF88.5
2024-04-0157
OAAI
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
2023-09-21413
OA
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
2023-08-2782
OAAI
Minor Myocardial Damage is a Prevalent Condition in Patients With Acute Heart Failure Syndromes and Preserved Systolic Function With Long-Term Prognostic Implications. A Report From the CIAST-HF (Collaborative Italo-Argentinean Study on Cardiac Troponin T in Heart Failure) Study
2012-11-0123
PREAI
Myocardial Damage Is a Prevalent Condition with Long-Term Prognostic Implications in Patients with Acute Heart Failure Syndromes and Preserved Systolic Function. A Report from the CIAST-HF (Collaborative Italo-Argentinean Study on Cardiac Troponin-T in Heart Failure) Study
2009-08-010
PREAI